SCHEMBL9602777

SCHEMBL9602777

CC(CN(C)C)Oc1ccc(N2N=C3c4cccc(Cl)c4SCC3CC2=O)cc1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.35
TOP1 P11387 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9865971 0.81 MCHR1 (0.35) MCHR1TOP1
SCHEMBL10559619 0.81 GABRP (0.39)
SCHEMBL9602906 0.80 MCHR1 (0.35) MCHR1TOP1
SCHEMBL9602580 0.78 MCHR1 (0.39) MCHR1TOP1
SCHEMBL9865071 0.77 MCHR1 (0.38) MCHR1TOP1
SCHEMBL9865444 0.77 MCHR1 (0.38) MCHR1TOP1
SCHEMBL9603147 0.75 MCHR1 (0.35) MCHR1TOP1
SCHEMBL9602794 0.74 CHRM2 (0.32)
SCHEMBL7288041 0.72 MAPT (0.34)
SCHEMBL9602271 0.72 MCHR1 (0.39) MCHR1TOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0351435-B1 FUSED PYRIDAZINE COMPOUNDS AND THEIR MEDICINAL USES Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1993-08-04 EP disclosed
US-5045541-A Immunodeficiency disorders YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1991-09-03 US disclosed
EP-0351435-A1 FUSED PYRIDAZINE COMPOUNDS AND THEIR MEDICINAL USES Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1990-01-24 EP disclosed